Novavax and CureVac among several biotechs with new CEOs; Michel Vounatsos, John Tsai land board appointments
→ Stanley Erck finally crossed a regulatory goal line at Novavax. And now he’s ready to walk off the field for the last time as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
